Ipsen and Medicis hope Reloxin will rival Botox

Published: 20-May-2008

The US Federal Drug Administration (FDA) has accepted a marketing application for a competitor product to Allergan's anti-wrinkle agent Botox from the French independent drugmaker Ipsen. The company says its Reloxin is a botulic toxin close to Botox. The product would be commercialised in the US by the No 2 aesthetic medicine group Medicis.


The US Federal Drug Administration (FDA) has accepted a marketing application for a competitor product to Allergan's anti-wrinkle agent Botox from the French independent drugmaker Ipsen. The company says its Reloxin is a botulic toxin close to Botox. The product would be commercialised in the US by the No 2 aesthetic medicine group Medicis.

Ipsen's share price moved up 5.1% on the Paris Bourse on the news to €41.49. The FDA earlier refused to accept an application for the product on the ground that the dossier was incomplete. Ipsen's partner Medicis is to pay Ipsen about $25m on this latest announcement and if marketing approval is granted, will pay Ipsen a further $75m.

Development and distribution rights in Reloxin were granted to the US company in early 2006 for the US, Canada and Japan.

See more

You may also like

Colour Cosmetics

Kris Jenner makes MAC Cosmetics debut fronting Studio Fix campaign

Read more
Momager Jenner fronts the make-up giant’s latest campaign and joins a growing list of Gen X celebrities which are being tapped by beauty businesses in 2025

Trending Articles

  1. Seen snaps up former Ulta Beauty boss as Chief Marketing Officer Linh Peters previously served as Head of Loyalty Marketing and Strategy at Ulta Beauty, overseeing the US beauty retailer’s loyalty programme and personalisation engine
  2. L'Oréal, LVMH and Luxottica named preferred buyers of Giorgio Armani empire The late Italian fashion designer has given purchasing priority to L'Oréal, along with LVMH, owned by the world’s richest man, Arnault Bernard, and eyewear brand Luxottica
  3. Glossier names Colin Walsh CEO as it aims to become ‘a true legacy brand’ Walsh, who has previously helmed the beauty divisions of Ouai and Procter & Gamble, will join the beauty company in October
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Maison Francis Kurkdjian turns heads with new $28,000 bottle of Baccarat Rouge 540 The fragrance giant has shocked consumers with its latest launch. Only 54 bottles of new Baccarat Rouge 540 Édition Millésime will be created each year, housed in a red crystal bottle with a 24-carat gold cap
  5. La Roche-Posay lands Law Roach for punny partnership marking 50th anniversary The L’Oréal-owned skin care brand has brought in the celebrity stylist alongside a cast of experts and creators for its ‘Brand Name’ Campaign in an attempt to connect with younger generations

Upcoming event

13th Annual Beauty Trends & Innovations Conference

24 September 2025 | London, UK See all

You may also like

Colour Cosmetics

Kris Jenner makes MAC Cosmetics debut fronting Studio Fix campaign

Momager Jenner fronts the make-up giant’s latest campaign and joins a growing list of Gen X celebrities which are being tapped by beauty businesses in 2025
You need to be a subscriber to read this article.
Click here to find out more.
Retail

Meet BeautyShelf: the beauty app making the girls' group chat shoppable

Meet the best friends-turned-co-founders setting out to give the group chat a shoppable glow up that has already partnered with Space NK and Sephora
Finance

Tropic Skincare founder Susie Ma lands £20 million payout after Lord Alan Sugar buyback

The payout came amid a bumper year of trading for the skin care business in 2024, as revenues and pre-tax profits both saw significant gains
Retail

Sephora to launch ‘shoppable storefronts’ where influencers can curate beauty product buys

Content creators will be able to monetise their recommendations of Sephora beauty brands from next month
Finance

Natura & Co inks deal to sell Avon business in Central America

Brazilian beauty conglomerate Natura & Co has agreed to offload its Avon business in Guatemala, Nicaragua, Panama, Honduras, El Salvador, and the Dominican Republic to Grupo PDC
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

What is fenugreek?

Vincent Miralles discusses fenugreek’s potential in sustainable polymers for next-generation hair care
Finance

Kolmar Korea launches full operation of 2nd US factory, establishing K-beauty’s ‘tariff safe zone’ in America

New 17,805㎡ facility completed in Pennsylvania with an annual production capacity of 300 million units
Subscribe now